Note: Ingredients listed on restricted chemical lists
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2026-01-21
Product name
ITOVEBI Tablets 3 mg
Product Synonyms
Inavolisib Drug Product FC Tablets 3 mg GDC-0077
1.2.1 Relevant identified uses
Formulated pharmaceutical active substance
supplier name
Genentech, Inc
Emergency telephone
001-(650) 225-1000, (800)-424-9300
Icons in SDS
Company Information
company name
Genentech, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350, H361fd, H372
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
Other hazards
None known
Signal word
Danger
Hazard statements
H350 May cause cancer. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child. H372 Causes damage to organs through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves, protective clothing, eye protection and face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
2.1 Classification of the substance or mixture
1910.1200) Hazards for the product as supplied Carcinogenicity : Category 1B Reproductive toxicity : Category 2 Specific target organ toxicity : Category 1 - repeated exposure Other hazards
